Table 3 Laboratory and treatment characteristics of the 220 HIV positive women by hr HPV infection status
Variables | Number of women n = 220 (%) | hr HPV infection status | OR; 95% confidence interval (CI) | |
|---|---|---|---|---|
hr HPV positive status | hr HPV negative status | |||
n = 101 (%) | n = 414 (%) | |||
CD4 cell count (Cells/mm3) | Â | Â | Â | Â |
< 200 | 22 (10.0) | 12 (54.5) | 10 (45.5) | 3.1 (1.1-9.1) |
200 – 499 | 86 (39.1) | 24 (27.9) | 62 (72.1) | 1 (ref) |
>500 | 112 (50.9) | 18 (16.1) | 94 (83.9) | 0.5 (0.2-1.0) |
HIV viral load (Copies/ml) | Â | Â | Â | Â |
<1000 | 136 (61.8) | 19 (14.0) | 117 (86.0) | 0.5 (0.2-1.8) |
1000 – 9999 | 26 (121.8) | 6 (23.1) | 20 (76.9) | 1 (ref) |
>10,000 | 58 (26.4) | 29 (50.0) | 29 (50.0) | 3.3 (1.1-10.9) |
Antiretroviral drug use | Â | Â | Â | Â |
Not on drugs | 61 (27.7) | 24 (39.3) | 37 (60.7) | 1 (ref) |
On drugs | 159 (72.3) | 30 (18.9) | 129 (81.1) | 0.4 (0.2-0.7) |